Sign in to view content

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema

Victor Hugo Gonzalez, MD

Video
Published 2024

Related

Brolucizumab for Neovascular AMD: The 2 Year HAWK and HARRIER Results
Pravin U. Dugel, MD
Updates from the Field
2018
Loss to Follow-up in Patients With Proliferative Diabetic Retinopathy Treated With Anti-VEGF Therapy and/or PRP in the United States
Rahul N. Khurana, MD, FASRS
Annual Meeting Talks
2021
Delayed and Loss of Follow-Up in Patients Receiving Intravitreal Injections for Diabetic Macular Edema
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2017

Category: Diabetic Retinopathy

See more